TPG Capital and Exactech amend deal terms
TPG Capital and Exactech have amended the details of their previously announced deal. According to the new terms, TPG Capital has agreed to acquire Exactech in a take-private buyout for $49.25 per share as opposed to the previously agreed amount of $42 per share. After the closing of the deal, Exactech will no longer trade on the NASDAQ. J.P. Morgan Securities LLC is serving as financial adviser to Exactech on the transaction. Greenberg Traurig, P.A. (Miami) and Greenberg Traurig, LLP (NYC) are providing legal advice to Exactech while Ropes & Gray is legal adviser to TPG. Based in Gainesville, Florida, Exactech is a developer of orthopaedic implant devices and surgical instrumentation for extremities and large joints.
4 December 2017•4 mins read
